Test Menu

Explore DRW’s portfolio of molecular tests

SAMBA II SARS-CoV-2 Test

In vitro nucleic acid amplification test for the qualitative detection of SARS-CoV-2 in human nasal and throat swabs.

SAMBA II SCoV-2/Flu/RSV Test

In vitro nucleic acid amplification test for the qualitative detection of SARS-CoV-2, Influenza A, Influenza B and/or Respiratory Syncytial Virus (RSV) in human respiratory specimens (combined nose and throat swabs).

SAMBA II SARS-CoV-2/FluA/FluB Test

Nucleic-acid based amplification test for the qualitative detection of nucleic acids from SARS-CoV-2, Influenza A and/or Influenza B in human respiratory specimens (combined nasal and throat, nasal or nasopharyngeal swabs).

SAMBA II SARS-CoV-2/RSV Test

Nucleic-acid based amplification test for the qualitative detection of nucleic acids from SARS-CoV-2 and/or Respiratory Syncytial Virus (RSV) in human respiratory specimens (combined nasal and throat/nasal/nasopharyngeal swabs).

SAMBA II HIV-1 Qualitative Whole Blood Test

The HIV-1 Qual Whole Blood Test is an in vitro nucleic acid amplification-based test (NAT) for the detection of HIV-1 viral RNA and pro-viral DNA for use on the SAMBA II platform.

SAMBA II HIV-1 Semi-Q Plasma Test

The SAMBA HIV-1 Semi-Q Test is an in vitro nucleic acid amplification-based test (NAT) for the semi-quantitative detection of HIV-1 viral RNA in plasma at the WHO recommended cut-off of 1000 copies/mL for use on the SAMBA II platform.

SAMBA II HIV-1 Semi-Quantitative Whole Blood Test

In vitro nucleic acid amplification test for the semi-quantitative detection of HIV-1 in human whole blood.

SAMBA II HCV Qualitative Whole Blood Test

In vitro nucleic acid amplification test for the qualitative detection of HCV viral RNA in human whole blood.